Patents by Inventor Gerhard Gross

Gerhard Gross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9180784
    Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems for using and operating electric vehicle charging stations (“EVCSs”) or electric vehicle supply equipment (“EVSE”) having a touch screen. The touch screen display device can be used, for example, to facilitate user interface with the EVCS/EVSE. The touch screen display apparatus can provide a quick and efficient means for a user to input a wide variety of information. Also disclosed herein are representative embodiments of a network communication system for EVCSs or EVSE.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: November 10, 2015
    Assignee: Optimization Technologies, Inc.
    Inventors: Dexter Turner, James B. Wakeen, Richard L. Knight, Martin D. Dill, Gerhard Gross
  • Publication number: 20150079096
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an inhibitor of the interaction between A? globulomer and the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Application
    Filed: October 14, 2014
    Publication date: March 19, 2015
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruhl, Christiane Grimm, Carsten Krantz
  • Patent number: 8895004
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an inhibitor of the interaction between A? globulomer and the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: November 25, 2014
    Assignee: AbbVie Deutschland GmbH & Co. KG
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruhl, Christine Grimm, Carsten Krantz
  • Publication number: 20140323494
    Abstract: The invention relates to N-phenyl-2-pyrimidine-amine derivatives in which at least one nitrogen atom carries an oxygen atom to form the corresponding N-oxides, to processes for the preparation thereof, to pharmaceutical compositions comprising those compounds, and to the use thereof in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans.
    Type: Application
    Filed: July 14, 2014
    Publication date: October 30, 2014
    Applicant: Novartis AG
    Inventors: Klaus O. Börnsen, Peter End, Gerhard Gross, Ulrike Pfaar, Paul W. Manley, Jürg Zimmermann
  • Publication number: 20140097795
    Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems for using and operating electric vehicle charging stations (“EVCSs”) or electric vehicle supply equipment (“EVSE”) having a touch screen. The touch screen display device can be used, for example, to facilitate user interface with the EVCS/EVSE. The touch screen display apparatus can provide a quick and efficient means for a user to input a wide variety of information. Also disclosed herein are representative embodiments of a network communication system for EVCSs or EVSE.
    Type: Application
    Filed: December 9, 2013
    Publication date: April 10, 2014
    Applicant: Optimization Technologies, Inc.
    Inventors: Dexter Turner, James B. Wakeen, Richard L. Knight, Martin D. Dill, Gerhard Gross
  • Patent number: 8604750
    Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems for using and operating electric vehicle charging stations (“EVCSs”) or electric vehicle supply equipment (“EVSE”) having a touch screen. The touch screen display device can be used, for example, to facilitate user interface with the EVCS/EVSE. The touch screen display apparatus can provide a quick and efficient means for a user to input a wide variety of information. Also disclosed herein are representative embodiments of a network communication system for EVCSs or EVSE.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: December 10, 2013
    Assignee: Optimization Technologies, Inc.
    Inventors: Dexter Turner, James B. Wakeen, Richard L. Knight, Martin D. Dill, Gerhard Gross
  • Publication number: 20110294820
    Abstract: The invention relates to N-phenyl-2-pyrimidine-amine derivatives derivatives in which at least one nitrogen atom carries an oxygen atom to form the corresponding N-oxides, to processes for the preparation thereof, to pharmaceutical compositions comprising those compounds, and to the use thereof in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans.
    Type: Application
    Filed: July 5, 2011
    Publication date: December 1, 2011
    Inventors: Klaus Olaf Börnsen, Peter End, Gerhard Gross, Ulrike Pfaar, Paul William Manley, Jürg Zimmerman
  • Publication number: 20110239116
    Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems for using and operating electric vehicle charging stations (“EVCSs”) or electric vehicle supply equipment (“EVSE”) having a touch screen. The touch screen display device can be used, for example, to facilitate user interface with the EVCS/EVSE. The touch screen display apparatus can provide a quick and efficient means for a user to input a wide variety of information. Also disclosed herein are representative embodiments of a network communication system for EVCSs or EVSE.
    Type: Application
    Filed: February 23, 2011
    Publication date: September 29, 2011
    Inventors: Dexter Turner, James B. Wakeen, Richard L. Knight, Martin D. Dill, Gerhard Gross
  • Publication number: 20110130549
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an inhibitor of the interaction between A? globulomer and the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Application
    Filed: February 27, 2008
    Publication date: June 2, 2011
    Applicant: ABBOTT GMBH & CO. KG
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruehl, Christiane Grimm, Carsten Krantz
  • Publication number: 20100311767
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an agonist of the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Application
    Filed: February 27, 2008
    Publication date: December 9, 2010
    Applicant: ABBOTT GMBH & CO. KG
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruhl, Christine Grimm, Carsten Krantz
  • Publication number: 20100234467
    Abstract: The present invention provides a method for improving the bioavailability of a renin inhibitor, preferably, of a ?-amino-?-hydroxy-?-aryl-alkanoic acid derivative, which method comprises co-administering to a mammal, especially a human, in need of such treatment, a combination of a renin inhibitor, or a pharmaceutically acceptable salt thereof, and an MDR1 inhibitor selected from a non-pharmacologically active compound.
    Type: Application
    Filed: November 23, 2007
    Publication date: September 16, 2010
    Inventors: Isabel Ottinger, Gian P. Camenisch, Gerhard Gross, Thomas Faller
  • Publication number: 20100222362
    Abstract: The invention relates to N-phenyl-2-pyrimidine-amine derivatives derivatives in which at least one nitrogen atom carries an oxygen atom to form the corresponding N-oxides, to processes for the preparation thereof, to pharmaceutical compositions comprising those compounds, and to the use thereof in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans.
    Type: Application
    Filed: May 17, 2010
    Publication date: September 2, 2010
    Inventors: Klaus Olaf Börnsen, Peter End, Gerhard Gross, Ulrike Pfaar, Paul William Manley, Jürg Zimmermann
  • Publication number: 20100209400
    Abstract: This invention is directed to methods, nucleic acids and compositions in TAK1-mediated regulation of SMAD activity. Promotion of TAK1 interaction with MH2 domains in SMADs negatively regulates SMAD biological activity. BMP-mediated SMAD activity is subject to TAK1 effects.
    Type: Application
    Filed: November 30, 2009
    Publication date: August 19, 2010
    Inventors: Dan Gazit, Gadi Pelled, Gadi Turgeman, Andrea Hoffmann, Gerhard Gross, Claas Wodarczyk, Kristin Verschueren
  • Patent number: 7709532
    Abstract: The present invention provides a method for improving the bioavailability of a renin inhibitor, preferably, of a ?-amino-?-hydroxy-?-aryl-alkanoic acid derivative, which method comprises co-administering to a mammal, especially a human, in need of such treatment, a combination of a renin inhibitor, or a pharmaceutically acceptable salt thereof, and an efflux protein inhibitor.
    Type: Grant
    Filed: August 2, 2005
    Date of Patent: May 4, 2010
    Assignee: Novartis AG
    Inventors: Gian P. Camenisch, Gerhard Gross, Isabel Ottinger, Daniel Wasmuth
  • Publication number: 20100071387
    Abstract: The method for cooling a liquid (2) in which a coolant comprising a refrigeration-liquefied gas is introduced into the liquid (2) and the corresponding device (1) make possible, in an advantageously simple manner, the production of cooled liquids (2), which, for example, can be used as process water in the production of freshly mixed concrete. In this case the enthalpy content of the coolant, preferably of liquid nitrogen, is utilized in a good manner, by firstly using the vaporization enthalpy, and secondly the heating of the nitrogen after vaporization up to ice temperature, for cooling the liquid.
    Type: Application
    Filed: April 3, 2008
    Publication date: March 25, 2010
    Applicant: L'Air Liquide Societe Anonyme Pour L'Etude Et L'Exploitation Des Procedes Georges Claude
    Inventors: Gerhard Gross, Johannes Beuse, Thomas Kutz, Friedel Theissen, Marc Sporing
  • Publication number: 20090306160
    Abstract: The invention provides a method for improving the bioavailability, preferably, oral bioavailability and/or drug disposition, e.g. brain penetration, of an iron chelator, which method comprises co-administering to a mammal, especially a human, in need of such treatment, a combination of an iron chelator and an efflux protein inhibitor.
    Type: Application
    Filed: June 9, 2009
    Publication date: December 10, 2009
    Inventors: Gian P. Camenisch, Hanspeter Nick, Gerhard Gross
  • Publication number: 20090239879
    Abstract: The invention relates to N-phenyl-2-pyrimidine-amine derivatives derivatives in which at least one nitrogen atom carries an oxygen atom to form the corresponding N-oxides, to processes for the preparation thereof, to pharmaceutical compositions comprising those compounds, and to the use thereof in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans.
    Type: Application
    Filed: June 4, 2009
    Publication date: September 24, 2009
    Inventors: Klaus Olaf BORNSEN, Peter END, Gerhard GROSS, Ulrike PFAAR, Paul William MANLEY, Jurg ZIMMERMANN
  • Patent number: 7557105
    Abstract: The invention relates to N-phenyl-2-pyrimidine-amine derivatives in which at least one nitrogen atom carries an oxygen atom to form the corresponding N-oxides, to processes for the preparation thereof, to pharmaceutical compositions comprising those compounds, and to the use thereof in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans.
    Type: Grant
    Filed: January 22, 2003
    Date of Patent: July 7, 2009
    Assignee: Novartis AG
    Inventors: Klaus Olaf Börnsen, Peter End, Gerhard Gross, Ulrike Pfaar, Paul William Manley, Jürg Zimmermann
  • Patent number: 7504099
    Abstract: This invention provides method for repairing, regenerating, treating, or inducing the repair of an injury, a defect or a condition of a connective tissue of a subject. This invention provides a method of regenerating, enhancing, inducing repair and/or development of connective tissue as a result of a defect, injury or condition of the connective tissue of a subject comprising the step of inserting an engineered cell which comprises a nucleic acid encoding a SMAD protein or variant thereof, so as to induce regeneration, repair and/or development of the connective tissue. This invention further provides methods of ex-vivo implantation of engineered cells into an injury, defect or condition of the connective tissue. This invention also provides a nucleic acid encoding a SMAD 8 protein variant, cells comprising such SMAD 8 variant, include mesenchymal stem cells, progenitor cells or cells derived from a connective tissue. Lastly, this invention provides SMAD 8 protein variant.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: March 17, 2009
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Dan Gazit, Gadi Pelled, Gadi Turgeman, Andrea Hoffmann, Peter Eberle, Gerhard Gross
  • Publication number: 20080214445
    Abstract: The invention relates to a method of treating a warm-blooded animal having a solid tumor disease comprising administering a combination which comprises (a) a N-phenyl-2-pyrimidine-amine derivative, especially N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine.
    Type: Application
    Filed: June 21, 2006
    Publication date: September 4, 2008
    Inventors: Sebastien Bihorel, Gerhard Gross, Michel Lemaire, Gian P. Camenisch